中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
20期
204-206
,共3页
慢性阻塞性肺疾病急性发作%2型糖尿病%糖皮质激素%血糖%安全
慢性阻塞性肺疾病急性髮作%2型糖尿病%糖皮質激素%血糖%安全
만성조새성폐질병급성발작%2형당뇨병%당피질격소%혈당%안전
Acute exacerbation chronic obstructive of pulmonary disease%Type 2 diabetes%Glucocorticoids%Blood sugar%Safety
目的:观察慢性阻塞性肺疾病急性发作(AECOPD)合并2型糖尿病(T2DM)患者在治疗过程中使用糖皮质激素后其血糖变化情况与胰岛素用量的关系。方法搜集我院住院患者中AECOPD且合并T2DM患者病例50例,入院时立即查血糖,并评估病情了解其是否需要使用糖皮质激素,及使用胰岛素的情况。使用糖皮质激素后开始监测空腹、餐后和(或)随机血糖,记录胰岛素调整剂量。采用SPSS13.0统计软件统计,(x ± s),Z检验,计算P值。结果使用糖皮质激素后AECOPD合并T2DM患者的各时段血糖数值有升高,差异均无统计学意义(P>0.05),日均胰岛素使用量增加明显,差异有统计学意义(P=0.0092)。结论AECOPD合并T2DM患者使用糖皮质激素安全,可控。
目的:觀察慢性阻塞性肺疾病急性髮作(AECOPD)閤併2型糖尿病(T2DM)患者在治療過程中使用糖皮質激素後其血糖變化情況與胰島素用量的關繫。方法搜集我院住院患者中AECOPD且閤併T2DM患者病例50例,入院時立即查血糖,併評估病情瞭解其是否需要使用糖皮質激素,及使用胰島素的情況。使用糖皮質激素後開始鑑測空腹、餐後和(或)隨機血糖,記錄胰島素調整劑量。採用SPSS13.0統計軟件統計,(x ± s),Z檢驗,計算P值。結果使用糖皮質激素後AECOPD閤併T2DM患者的各時段血糖數值有升高,差異均無統計學意義(P>0.05),日均胰島素使用量增加明顯,差異有統計學意義(P=0.0092)。結論AECOPD閤併T2DM患者使用糖皮質激素安全,可控。
목적:관찰만성조새성폐질병급성발작(AECOPD)합병2형당뇨병(T2DM)환자재치료과정중사용당피질격소후기혈당변화정황여이도소용량적관계。방법수집아원주원환자중AECOPD차합병T2DM환자병례50례,입원시립즉사혈당,병평고병정료해기시부수요사용당피질격소,급사용이도소적정황。사용당피질격소후개시감측공복、찬후화(혹)수궤혈당,기록이도소조정제량。채용SPSS13.0통계연건통계,(x ± s),Z검험,계산P치。결과사용당피질격소후AECOPD합병T2DM환자적각시단혈당수치유승고,차이균무통계학의의(P>0.05),일균이도소사용량증가명현,차이유통계학의의(P=0.0092)。결론AECOPD합병T2DM환자사용당피질격소안전,가공。
Objective To observe the changes of blood glucose on patients with acute exacerbation chronic obstructive of pulmonary disease and type 2 diabetes after using corticosteroids in the treatment process and the relationship to the insulin dosage. Methods 50 cases of patients in our hospital with T2DM and AECOPD were collected, and they were checked blood sugar immediately after admission, and the condition about whether they need the use of corticosteroids and the use of insulin were assessed. After the use of glucocorticoids,the fasting,postprandial and / or random blood glucose were monitored , insulin dose adjustment was record. Using statistical software SPSS13.0 ,(x ± s),Z test, P value was calculated. Results Each period of blood glucose in patients with AECOPD and T2DM values were elevated after the use of glucocorticoids, P>0.05, the difference was not statistically significant, the average daily insulin usage increased significantly, P=0.0092, the difference had statistical significance. Conclusion The glucocorticoid use in patients with AECOPD and T2DM is safety, controllable.